Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373399 · ClinicalTrials.gov registry record · Phase 1
Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT00373399 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 36 participants.
The verdict
NCT00373399, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of smoked marijuana on both risk taking and decision making tasks.
Interventions
- DRUG Inactive Marijuana (0% THC)
- DRUG Low THC marijuana (1.8 %THC)
- DRUG High THC marijuana (3.9% THC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-05 |
| Est. Completion | 2008-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373399
The ClinicalTrials.gov registry entry for NCT00373399 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Inactive Marijuana (0% THC) is the first listed.
NCT00373399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00373399 about?
NCT00373399 is a clinical study titled "Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks". The purpose of this study is to investigate the effects of smoked marijuana on both risk taking and decision making tasks.
What is the current status of trial NCT00373399?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2006-05. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00373399?
The interventions under investigation include: Inactive Marijuana (0% THC) (DRUG), Low THC marijuana (1.8 %THC) (DRUG), High THC marijuana (3.9% THC) (DRUG).
Who is sponsoring clinical trial NCT00373399?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.